New pharmaceutical composition, useful for preventing or treating viral or bacterial infections caused by a pathogen selected from HIV-1 virus, Ebola virus, hepatitis C virus, Mycobacterium tuberculosis and Helicobacter pylori

摘要

A pharmaceutical composition comprising polypeptide comprising any of fully defined 135 amino acids (SEQ ID NO1-3) given in the specification, is new. An independent claim is a complementary DNA (cDNA) encoding for polypeptide comprising any of SEQ ID NO. 1-3. ACTIVITY : Virucide; Antibacterial; Anti-HIV; Antiinflammatory; Hepatotropic; Antitubercular; Tuberculostatic. No biological data given. MECHANISM OF ACTION : None given.